Search Results - "HIRSCH, C"

Refine Results
  1. 1

    Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease by Hirsch, Etienne C., Standaert, David G.

    Published in Movement disorders (01-01-2021)
    “…Parkinson's disease is a progressive and debilitating disorder that has so far eluded attempts to develop disease‐modifying treatment. Both epidemiological and…”
    Get full text
    Journal Article
  2. 2

    Neuroinflammation in Parkinson's disease: a target for neuroprotection? by Hirsch, Etienne C, PhD, Hunot, Stéphane, PhD

    Published in Lancet neurology (01-04-2009)
    “…Summary Parkinson's disease is characterised by a slow and progressive degeneration of dopaminergic neurons in the substantia nigra. Despite intensive…”
    Get full text
    Journal Article
  3. 3

    Pathogenesis of Parkinson's disease by Hirsch, Etienne C., Jenner, Peter, Przedborski, Serge

    Published in Movement disorders (01-01-2013)
    “…Parkinson's disease is a common adult‐onset neurodegenerative disorder whose pathogenesis remains essentially unknown. Currently, it is believed that the…”
    Get full text
    Journal Article
  4. 4

    Missing pieces in the Parkinson's disease puzzle by Obeso, Jose A, Rodriguez-Oroz, Maria C, Goetz, Christopher G, Marin, Concepcion, Kordower, Jeffrey H, Rodriguez, Manuel, Hirsch, Etienne C, Farrer, Matthew, Schapira, Anthony H V, Halliday, Glenda

    Published in Nature medicine (01-06-2010)
    “…Parkinson's disease is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based…”
    Get full text
    Journal Article
  5. 5

    Can a decision support system accelerate rare disease diagnosis? Evaluating the potential impact of Ada DX in a retrospective study by Ronicke, Simon, Hirsch, Martin C, Türk, Ewelina, Larionov, Katharina, Tientcheu, Daphne, Wagner, Annette D

    Published in Orphanet journal of rare diseases (21-03-2019)
    “…Rare disease diagnosis is often delayed by years. A primary factor for this delay is a lack of knowledge and awareness regarding rare diseases. Probabilistic…”
    Get full text
    Journal Article
  6. 6

    Genomic determinants of chronic myelomonocytic leukemia by Patel, B J, Przychodzen, B, Thota, S, Radivoyevitch, T, Visconte, V, Kuzmanovic, T, Clemente, M, Hirsch, C, Morawski, A, Souaid, R, Saygin, C, Nazha, A, Demarest, B, LaFramboise, T, Sakaguchi, H, Kojima, S, Carraway, H E, Ogawa, S, Makishima, H, Sekeres, M A, Maciejewski, J P

    Published in Leukemia (01-12-2017)
    “…The biology, clinical phenotype and progression rate of chronic myelomonocytic leukemia (CMML) are highly variable due to diverse initiating and secondary…”
    Get full text
    Journal Article
  7. 7

    Bee venom and its component apamin as neuroprotective agents in a Parkinson disease mouse model by Alvarez-Fischer, Daniel, Noelker, Carmen, Vulinović, Franca, Grünewald, Anne, Chevarin, Caroline, Klein, Christine, Oertel, Wolfgang H, Hirsch, Etienne C, Michel, Patrick P, Hartmann, Andreas

    Published in PloS one (18-04-2013)
    “…Bee venom has recently been suggested to possess beneficial effects in the treatment of Parkinson disease (PD). For instance, it has been observed that…”
    Get full text
    Journal Article
  8. 8

    Vasoactive-inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass by Gaies, Michael G, Gurney, James G, Yen, Alberta H, Napoli, Michelle L, Gajarski, Robert J, Ohye, Richard G, Charpie, John R, Hirsch, Jennifer C

    Published in Pediatric critical care medicine (01-03-2010)
    “…Inotrope score has been proposed as a marker of illness severity after pediatric cardiac surgery despite a lack of data to support its use as such. The goal of…”
    Get full text
    Journal Article
  9. 9

    The iron-binding protein lactoferrin protects vulnerable dopamine neurons from degeneration by preserving mitochondrial calcium homeostasis by Rousseau, Erwann, Michel, Patrick P, Hirsch, Etienne C

    Published in Molecular pharmacology (01-12-2013)
    “…Previous studies on postmortem human brain tissue have shown that the iron-binding glycoprotein lactoferrin is upregulated in dopamine (DA) neurons resistant…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Understanding Dopaminergic Cell Death Pathways in Parkinson Disease by Michel, Patrick P., Hirsch, Etienne C., Hunot, Stéphane

    Published in Neuron (Cambridge, Mass.) (18-05-2016)
    “…Parkinson disease (PD) is a multifactorial neurodegenerative disorder, the etiology of which remains largely unknown. Progressive impairment of voluntary motor…”
    Get full text
    Journal Article
  12. 12

    Multi-objective optimization of turbomachinery using improved NSGA-II and approximation model by Wang, X.D., Hirsch, C., Kang, Sh, Lacor, C.

    “…Coupled optimization methods based on multi-objective genetic algorithms and approximation models are widely used in engineering optimizations. In the present…”
    Get full text
    Journal Article
  13. 13

    The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease by DAMIER, P, HIRSCH, E. C, AGID, Y, GRAYBIEL, A. M

    Published in Brain (London, England : 1878) (01-08-1999)
    “…To achieve accuracy in studying the patterns of loss of midbrain dopamine-containing neurons in Parkinson's disease, we used compartmental patterns of…”
    Get full text
    Journal Article
  14. 14
  15. 15

    JNK-Mediated Induction of Cyclooxygenase 2 Is Required for Neurodegeneration in a Mouse Model of Parkinson's Disease by Hunot, Stéphane, Vila, Miquel, Teismann, Peter, Davis, Roger J., Hirsch, Etienne C., Przedborski, Serge, Rakic, Pasko, Flavell, Richard A.

    “…Parkinson's disease (PD) is a neurodegenerative disorder characterized by loss of dopamine-containing neurons, but the molecular pathways underlying its…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    Health economic benefits through the use of diagnostic support systems and expert knowledge by Willmen, Tina, Völkel, Lukas, Ronicke, Simon, Hirsch, Martin C, Kaufeld, Jessica, Rychlik, Reinhard P, Wagner, Annette D

    Published in BMC health services research (09-09-2021)
    “…Rare diseases are difficult to diagnose. Due to their rarity, heterogeneity, and variability, rare diseases often result not only in extensive diagnostic tests…”
    Get full text
    Journal Article
  20. 20

    A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis by Ribeiro‐Rodrigues, R., Resende Co, T., Rojas, R., Toossi, Z., Dietze, R., Boom, W. H., Maciel, E., Hirsch, C. S.

    Published in Clinical and experimental immunology (01-04-2006)
    “…Summary Active tuberculosis (TB) is associated with prolonged suppression of Mycobacterium tuberculosis (MTB)‐specific immune responses, but mechanisms…”
    Get full text
    Journal Article